20201030-wbr-impact307.jpg

Christoph Geisler, left, CEO and founder of Theraneutrics, discusses his research on a patent-pending probiotic to combat gout with James Francis, chief development officer for the startup company. The startup is housed in the IMPACT Laramie facility (formerly the Wyoming Technology Business Center) on the University of Wyoming campus, managed by the IMPACT 307 business innovation incubator. Veronica Donahue photo

One startup is designed as a B2B company, selling its technology and services to other businesses who are looking for an edge in wind energy designs. The other startup is a B2C company, developing a new treatment for gout to market to the public.

On the surface, the two startups don’t seem to have much in common. But a closer look reveals they share a lot of similarities in how they approach establishing themselves as businesses that will help grow and diversify Wyoming’s economy.

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.